Her primary scientific interests are in Cannabinoid receptor, Cannabinoid, Endocrinology, Internal medicine and Receptor. Catherine Ledent interconnects Developmental psychology, Knockout mouse, Neuroscience and Endocannabinoid system in the investigation of issues within Cannabinoid receptor. The Cannabinoid study combines topics in areas such as Cannabinoid Receptor Modulators, Immunology, Cannabinoid receptor type 2, Wild type and Elevated plus maze.
Her research integrates issues of Adenosine A2A receptor, Adenosine receptor and Pharmacology in her study of Endocrinology. Her Internal medicine research incorporates themes from Cytotoxic T cell, PTC Oncogene, Genetically modified mouse and T-cell receptor. Her Receptor research focuses on Cell biology and how it connects with Programmed cell death.
Her main research concerns Internal medicine, Endocrinology, Receptor, Pharmacology and Cannabinoid receptor. Internal medicine connects with themes related to Wild type in her study. Her Endocrinology research includes themes of Adenosine A2A receptor, Knockout mouse and CGS-21680.
Her Receptor research incorporates elements of Dopaminergic, Striatum and Cell biology. Her study in Pharmacology is interdisciplinary in nature, drawing from both Agonist, Nucleus accumbens, Dopamine and Caffeine. Her Cannabinoid receptor study combines topics from a wide range of disciplines, such as Cannabinoid, Neuroscience and Endocannabinoid system.
Catherine Ledent mainly focuses on Internal medicine, Endocrinology, Adenosine, Adenosine receptor and Pharmacology. Her study brings together the fields of Downregulation and upregulation and Internal medicine. Her Endocrinology research integrates issues from Cannabinoid, Knockout mouse, Epoxide hydrolase 2, Endocannabinoid system and Cannabinoid receptor.
Her Cannabinoid receptor study integrates concerns from other disciplines, such as Glutamate receptor, Glutamatergic and Neuroscience, Central nervous system. The various areas that Catherine Ledent examines in her Adenosine study include CGS-21680, Receptor, Coronary circulation, Reactive hyperemia and Adenosine A2A receptor. In her research on the topic of Pharmacology, Dopaminergic is strongly related with Nucleus accumbens.
Her primary areas of study are Adenosine A2A receptor, Endocrinology, Internal medicine, Adenosine and Adenosine receptor. Adenosine A2A receptor is the subject of her research, which falls under Receptor. Within one scientific family, Catherine Ledent focuses on topics pertaining to Caffeine under Receptor, and may sometimes address concerns connected to Receptor antagonist.
Her Endocrinology study combines topics in areas such as Cannabinoid and Chromatin remodeling. The study incorporates disciplines such as Macrophage and Pharmacology in addition to Adenosine. Her studies deal with areas such as Signal transduction, Cell biology, Knockout mouse and Coronary circulation as well as Adenosine receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice
Catherine Ledent;Olga Valverde;Gregorio Cossu;François Petitet.
Science (1999)
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.
Catherine Ledent;Jean-Marie Vaugeois;Serge N. Schiffmann;Thierry Pedrazzini.
Nature (1997)
Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission
István Katona;Ede A. Rancz;László Acsády;Catherine Ledent.
The Journal of Neuroscience (2001)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
Fatima Teixeira-Clerc;Boris Julien;Boris Julien;Pascale Grenard;Pascale Grenard;Jeanne Tran Van Nhieu;Jeanne Tran Van Nhieu.
Nature Medicine (2006)
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
Norbert Hájos;Catherine Ledent;Tamás F Freund.
Neuroscience (2001)
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
Norbert Hájos;István Katona;S S Naiem;Ken Mackie.
European Journal of Neuroscience (2000)
Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses
István Katona;Gabriella M. Urbán;Matthew Wallace;Catherine Ledent.
The Journal of Neuroscience (2006)
Involvement of CB1 cannabinoid receptors in emotional behaviour.
Miquel Martin;Catherine Ledent;Marc Parmentier;Rafael Maldonado.
Psychopharmacology (2002)
Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus.
Namita Varma;Gregory C. Carlson;Catherine Ledent;Bradley E. Alger.
The Journal of Neuroscience (2001)
Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A2B Adenosine Receptors
Tobias Eckle;Thomas Krahn;Almut Grenz;David Köhler.
Circulation (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Libre de Bruxelles
Pompeu Fabra University
Université Libre de Bruxelles
Université Libre de Bruxelles
Université Libre de Bruxelles
University of Lille
Semmelweis University
Indiana University
University of Washington
Queen Mary University of London
Oregon State University
University of Zurich
Hiroshima University
Graz University of Technology
University of Pavia
Griffith University
University of Natural Resources and Life Sciences
University of California, Berkeley
University of Tübingen
Technical University of Denmark
University of Tokyo
Institut National de la Recherche Scientifique
University of Otago
University of Bordeaux
National University of Singapore
University of Minnesota